FDA OKs new device for preserving donated lungs

08/12/2014 | News & Observer (Raleigh, N.C.), The

The FDA has approved the use of the XVIVO Perfusion System, a new device that preserves donated lungs for up to four hours as physicians assess whether the organ can be used for transplant. The device could allow for more successful lung transplants in patients with life-threatening respiratory conditions, the FDA said.

View Full Article in:

News & Observer (Raleigh, N.C.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY